Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease.
about
Anti-hypertensive Herbs and their Mechanisms of Action: Part IChinese Herbal Medicine on Cardiovascular Diseases and the Mechanisms of ActionAlternative medicine in atrial fibrillation treatment-Yoga, acupuncture, biofeedback and more.Therapeutic potentials of Crataegus azarolus var. eu- azarolus Maire leaves and its isolated compounds.Complementary and alternative medicine and cardiovascular disease: an evidence-based reviewVitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a.Motivations for Botanical Use by Socioeconomically Diverse, Urban Adults: Does Evidence Support Motivation?Hawthorn ethanolic extracts with triterpenoids and flavonoids exert hepatoprotective effects and suppress the hypercholesterolemia-induced oxidative stress in rats.Chemical Composition, Antioxidant, Anti-Inflammatory, and Antiproliferative Activities of the Plant Lebanese Crataegus Azarolus L.Heart ABCA1 and PPAR- α Genes Expression Responses in Male rats: Effects of High Intensity Treadmill Running Training and Aqueous Extraction of Black Crataegus-Pentaegyna.Herbs Used for the Treatment of Hypertension and their Mechanism of Action.Protective and therapeutic effects of Crataegus aronia in non-alcoholic fatty liver disease.Identification of Novel Melanin Synthesis Inhibitors From Crataegus pycnoloba Using an in Vivo Zebrafish Phenotypic Assay.A Review on the Effect of Traditional Chinese Medicine Against Anthracycline-Induced Cardiac Toxicity.Cardioprotective and Metabolomic Profiling of Selected Medicinal Plants against Oxidative Stress.Ethnobotany of Anti-hypertensive Plants Used in Northern Pakistan
P2860
Q26772791-A1B2A580-2215-4D07-9117-814231F07BA9Q28072623-CAE904B3-DFDD-4654-8401-496B0C64F173Q35062038-41D4BD47-0239-4E80-8EAF-12153953C67FQ36350268-841FA013-710D-41E7-BF50-C55D7407224AQ36846142-A2D0B088-C478-42F6-96FE-9B31A3AC091BQ37204101-33891F7A-AC17-486C-9046-C1F84D57C023Q39258614-EEE17840-C175-4DF7-A1D3-1223A0869E25Q40548708-F06BA3F5-6BDE-4814-B133-34C95FE5C403Q41360017-90C9681C-701B-49A3-95FC-03196A94B140Q41724065-D2397F7A-4C6B-4373-BA19-AD7A73503456Q50047464-2AB0C061-6349-40BB-9EF7-42D20C8742DAQ51636759-5BE4FFB2-E914-4855-A216-C9B2510D1E74Q52597680-CF7CCAC0-07AB-4AC8-9B32-AAD3D73B6ED7Q54942355-E3971F9F-A4AE-4631-A470-3111E47B147AQ54988985-EA8C4F43-038E-4913-9260-2C9C0170C11FQ57254350-58DC0C25-EC28-4ABE-8F4D-AFE1A4F25648
P2860
Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease.
@ast
Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease.
@en
type
label
Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease.
@ast
Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease.
@en
prefLabel
Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease.
@ast
Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease.
@en
P2093
P2860
P356
P1476
Hawthorn (Crataegus spp.) in the treatment of cardiovascular disease.
@en
P2093
Deirdre Gilroy
Mary C Tassell
Mary Lehane
Rosari Kingston
P2860
P356
10.4103/0973-7847.65324
P407
P577
2010-01-01T00:00:00Z